Gastrointestinal Stromal Tumor
📧 Sign up to get email alerts when something new happens for Gastrointestinal Stromal Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: CEH-EUS for Differentiating GISTs and Leiomyomas: A Multicenter Prospective Self-Controlled Study
A multicenter prospective self-controlled clinical trial evaluating contrast-enhanced harmonic endoscopic ultrasound (CEH-EUS) to differenti…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis
A multicenter observational study is evaluating multimodal artificial intelligence for diagnosing upper gastrointestinal mesenchymal tumors,…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment [Phase 2]
A Phase 2 clinical trial is evaluating regorafenib plus Envafolimab for metastatic Gastrointestinal Stromal Tumors with KIT exon 17 mutation…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: An International Study on Pediatric Patients With Rare Tumors.
An international pediatric clinical trial study focused on rare tumors is currently recruiting, covering multiple tumor types.
-
CLINICAL_TRIALS withdrawal · 2025-05-28Clinical Trial Update: Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019)
Expanded access to Everolimus for an individual patient with Gastrointestinal Stromal Tumor has ended and is no longer available.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States
This clinical trial update reports on an observational study evaluating the use of regorafenib in patients with advanced gastrointestinal st…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: GIST: Assessment of Tumor Mutations and TKI Plasma Exposure
A completed clinical trial update examining tumor mutation profiles and the plasma exposure of tyrosine kinase inhibitors in gastrointestina…
-
FDA approval · 2025-05-06FDA Approved: QINLOCK — Supplemental Application (Deciphera Pharmaceuticals, LLC)
FDA approved a supplemental application for QINLOCK (ripretinib) submitted by Deciphera Pharmaceuticals, LLC.
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery [NA]
This clinical trial update notes a prospective evaluation of the Cornerstone Robotics Sentire Surgical System in major gastrointestinal and …
-
FDA approval · 2025-04-14FDA Approved: IMATINIB MESYLATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' imatinib mesylate as an original (ANDA) generic product.
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site
Clinical trial update on a study comparing tumor efficacy and safety of laparoscopic resection for gastrointestinal stromal tumors of the st…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies
Completed clinical trial update evaluating the use of liquid biopsies to reduce cancer death risk during viral pandemics. The provided snipp…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
A multicenter Australia-New Zealand trial evaluating endoscopic tissue resection for upper gastrointestinal cancers; currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK
An observational quality-assessment study of sarcoma being conducted across European and Latin American multidisciplinary networks; recruitm…
-
FDA approval · 2025-03-20FDA Approved: IMATINIB MESYLATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for imatinib mesylate (Teva) under an ANDA, authorizing continued regulatory approval for this gener…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST [Phase 3]
An update on a Phase 3 trial comparing three versus five years of adjuvant imatinib in patients with operable gastrointestinal stromal tumor…
-
EMA approval · 2025-03-10EMA Authorised: Sutent (sunitinib) — Pfizer Limited
Sutent (sunitinib) has been authorised by the EMA with indications for gastrointestinal stromal tumor, renal cell carcinoma, and neuroendocr…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM
Completed clinical trial comparing liver resection, radiofrequency ablation, transarterial chemoembolization, and drug therapy in patients w…
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA
This clinical trial update covers the investigation of avapritinib for unresectable or recurrent/metastatic gastrointestinal stromal tumors …
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors
A multicenter clinical trial is evaluating the efficacy and safety of avapritinib for metastatic or unresectable gastrointestinal stromal tu…
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: The Correlation Between Ripretinib Exposure and the Efficacy and Safety in Patients with Advanced GISTs
A clinical trial update examining the relationship between ripretinib exposure and its efficacy and safety in patients with advanced gastroi…
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study
A real-world study investigating second-line pharmacotherapy patterns and outcomes in advanced gastrointestinal stromal tumors, currently in…
-
FDA approval · 2025-02-14FDA Approved: SUNITINIB MALATE — Original Application (Novadoz Pharmaceuticals LLC)
The FDA approved an original generic application for sunitinib malate from Novadoz Pharmaceuticals LLC. This approval provides a generic opt…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib [Phase 2]
Phase 2 trial evaluating DCC-2618 in combination with Sunitinib in patients with advanced gastrointestinal stromal tumor after imatinib fail…
-
FDA approval · 2025-01-08FDA Approved: IMATINIB MESYLATE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental ANDA for Imatinib Mesylate (Chartwell RX, LLC), enabling marketing of a generic version of the cancer drug.